Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

NCT03946943 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcomas
Undifferentiated Pleomorphic Sarcoma

Interventions

DRUG: Anlotinib
DRUG: Toripalimab
PROCEDURE: Blood Draw
PROCEDURE: Tumor Specimen Collection

Sponsor

Di Wu